In STAD, the M1-skewed (iNOS+) CD68+ population, despite PD-L1 co-localization, may retain anti-tumor activity through nitric oxide-mediated cytotoxicity, explaining the favorable prognosis. This evidence concerns the gene CD68 and gastric adenocarcinoma.